Frequently asked questions

Weight-loss injection FAQs

The questions South Africans actually ask about GLP-1 weight-loss medicines — grouped by topic and answered plainly. Always confirm specifics with a registered provider.

Medically reviewed by an HPCSA-registered doctor Last updated 8 sources

Getting started

They're weekly (or daily) injections of a GLP-1 receptor agonist — a medicine that mimics a gut hormone to reduce appetite, slow stomach emptying and steady blood sugar. In SA the main ones are Ozempic and Wegovy (semaglutide), Mounjaro (tirzepatide) and Saxenda (liraglutide). See how GLP-1 works.

You need a prescription from a registered doctor, and the medicine must come from a licensed pharmacy. The usual routes are an in-person GP or a reputable telehealth service (online scripts from around R250), with the medicine dispensed or couriered under cold chain. A registered provider is the safe place to start.

Yes — registered telehealth doctors can assess you and issue a prescription, with the medicine dispensed by a licensed pharmacy. Avoid any site that ships these medicines with no prescription or assessment; that's a red flag for counterfeits.

No. These are Schedule 4 prescription-only medicines. They can't be sold over the counter or without a valid prescription.

Clinicians generally consider them for adults with a BMI of 30+, or 27+ with a weight-related condition (type 2 diabetes, high blood pressure, sleep apnoea, etc.). It's a clinical decision — see am I eligible? and the BMI calculator.

Results & expectations

In trials, average weight loss (on top of diet and lifestyle) was roughly ~8% on Saxenda, ~15% on semaglutide and up to ~21% on tirzepatide. Real-world results are often a bit lower and vary widely between people. We never publish guarantees.

Many people notice reduced appetite and cravings within the first few weeks, with weight loss building over months as the dose increases. Full trial results were measured over 56–72 weeks.

Often, at least partly. Studies show meaningful weight regain after stopping, especially without sustained lifestyle changes — which is why these are usually viewed as long-term treatments. Discuss any stop/step-down plan with your provider.

Plateaus are normal. Your provider may review your dose, diet, activity, sleep and other medicines. Don't increase the dose faster than prescribed to push through a plateau.

They make eating less much easier, but they work best with a reasonable diet and some activity — and protecting muscle matters. See diet & lifestyle.

Side effects & safety

Mostly gastrointestinal — nausea, constipation, diarrhoea, reflux — usually worst when starting or increasing a dose, and easing over time. Our side effects guide covers management.

Smaller, blander meals; go easy on greasy and very rich food; stay hydrated; and don't rush dose increases. Tell your provider if it persists — slowing titration usually helps.

Less common but serious risks include pancreatitis and gallbladder problems, with cautions for certain thyroid conditions (medullary thyroid carcinoma / MEN 2). They're not for use in pregnancy. Seek urgent care for severe, persistent abdominal pain. This is why they're prescription-only.

Alcohol can worsen nausea, irritate the stomach and add empty kilojoules, and some people find their tolerance drops. It isn't necessarily off-limits, but go gently — especially early on and around dose changes. Ask your provider about your situation.

Generally not in pregnancy or breastfeeding, in the healthy/underweight BMI range, or with certain personal/family histories (e.g. medullary thyroid carcinoma, MEN 2) — among others. A provider will check your history. See am I eligible?

Rapid weight loss can cost some muscle. Enough protein plus a little resistance exercise helps protect it — see diet & lifestyle.

Choosing a medication

There's no single best — on average weight loss, tirzepatide (Mounjaro) leads, then semaglutide (Wegovy/Ozempic), then liraglutide (Saxenda); but price, availability, tolerance and registration also matter. See our balanced comparison.

Same ingredient (semaglutide). Wegovy is registered for weight management and reaches a higher dose (2.4 mg); Ozempic is registered for diabetes (weight-loss use is off-label) and tops out at 2 mg. See Ozempic vs Wegovy.

On average weight loss it produced more in a head-to-head trial (~20.2% vs 13.7% for semaglutide), but it's usually pricier. See Wegovy vs Mounjaro and Ozempic vs Mounjaro.

Oral semaglutide (Rybelsus) is registered in SA but not yet widely sold as of 2026. For now the effective weight-loss options are injections. See semaglutide.

Cost & medical aid

Roughly: Ozempic R2 700–R3 300, Wegovy about R1 900–R3 750 (after the 2026 cuts), Mounjaro R3 500–R4 600, Saxenda R2 800–R4 800 — before the consultation, blood tests and delivery. See the price guide.

At lower doses, Wegovy and Ozempic are often among the more affordable registered options; Saxenda's cost rises at the full daily dose. Be wary of “cheap” unregistered products — see compounded semaglutide.

Usually not for weight loss — obesity isn't a Prescribed Minimum Benefit. Some plans allow payment from a medical savings account. If you have type 2 diabetes, a GLP-1 like Ozempic may be covered under a chronic benefit with the right motivation. See medical-aid cover.

For weight loss, generally not as a chronic benefit; for type 2 diabetes it may be covered via the Chronic Illness Benefit if you meet the criteria. Confirm with Discovery. See medical-aid cover.

The consultation (from ~R250), baseline and follow-up bloods, needles, and cold-chain delivery — plus your monthly cost rises as the dose steps up. See the price guide.

Compounded & counterfeit

Compounded semaglutide is not SAHPRA-registered, so purity, dose and sterility aren't guaranteed and there's little recourse if something goes wrong. We'd urge caution — see our honest guide and use registered products from licensed pharmacies.

Not an approved generic at the time of writing. Cheaper “semaglutide” sold now is typically compounded or imported and unregistered.

Only use products dispensed by a licensed pharmacy on a valid prescription. Be wary of social-media sellers, couriers without a script, and prices that look too good. SAHPRA has warned about falsified semaglutide in SA.

Using your pen

The needles are very short and fine; most people feel little or nothing. See how to inject.

Into the fat just under the skin (subcutaneous) — the abdomen (away from the navel), front of the thighs, or back of the upper arms — rotating sites each time.

Keep unopened pens refrigerated (typically 2–8 °C), don't freeze, and follow the leaflet on how long an in-use pen can stay at room temperature. This is why it's couriered cold.

Guidance differs by medicine and how late you are — follow your patient information leaflet or ask your provider. Don't double up to “catch up”.

Still have a question?

If we haven't covered it, contact us and we'll try to help — or, for advice about your own health, speak to a registered provider .

Sources & references

We cite primary sources and paraphrase them. Last reviewed June 2026. See our editorial policy and full sources hub.

  1. 1SAHPRA — registered health products & safety alertsSouth African Health Products Regulatory Authority. SA registration status of medicines and counterfeit / falsified-product warnings.
  2. 2STEP programme — semaglutide for weight managementNew England Journal of Medicine (Wilding et al., STEP 1, 2021). Average weight loss with semaglutide 2.4 mg (~15% at 68 weeks).
  3. 3SURMOUNT-1 — tirzepatide for weight managementNew England Journal of Medicine (Jastreboff et al., 2022). Average weight loss with tirzepatide (up to ~21–22.5% at highest dose).
  4. 4SURMOUNT-5 — tirzepatide vs semaglutide head-to-headNew England Journal of Medicine (Aronne et al., 2025). Direct comparison favouring tirzepatide (~20.2% vs 13.7% weight loss).
  5. 5SCALE — liraglutide (Saxenda) for weight managementNew England Journal of Medicine (Pi-Sunyer et al., 2015). Average weight loss with liraglutide 3.0 mg (~8%).
  6. 6Weight-loss drugs are no quick fix / Chronic Illness BenefitDiscovery Health. Medical-aid funding context and chronic-benefit criteria.
  7. 7SA Medicine Price Registry (SEP database)National Department of Health. Single Exit Price reference for medicines sold in SA.
  8. 8Which breakthrough weight-loss medicines can you get in SA?Spotlight. SA availability and registration context for GLP-1 medicines.
Next step

Still weighing it up?

A registered provider can answer questions specific to your health, check your eligibility and start you safely on a genuine product.

Book a consultation → Registered providers · genuine medicines · licensed pharmacies